BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Intestine
,
Hematopoietic cell
,
Prozac
,
rs3825942
,
CXCL2
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
anti angiogenetic drug
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
SERPINA3
TNF
VEGFA
LCN2
LPL
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
organic cyclic compound binding
heterocyclic compound binding
cytosol
PILON_KLF1_TARGETS_DN
DODD_NASOPHARYNGEAL_CARCINOMA_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Sarcoma gene expression in tumors with good and poor responses to bevacizumab treatment
Expression data for effector T cells
Cord blood mononuclear cells depleted of PIM kinases under Th1 or Th2 polarizing conditions
Colorectal cancer patients - Bevacizumab responders and non-responders
Glioblastoma xenografts Avastin sensitive and resistant treated with Avastin
Explore Curated Studies Results
Literature
Most Relevant Literature
Efficacy and safety of angiogenesis inhibitors in melanoma: a meta-analysis of seven randomized cont…
Angiogenesis inhibitors: mechanism of action and nephrotoxicity].
Discovery of novel PROTACs based on multi-targeted angiogenesis inhibitors.
Angiogenesis inhibitors for the treatment of epithelial ovarian cancer.
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colore…
Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial
Probiotics for Improving Post-surgical Healing
Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuva…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ